colorectal cancer
Conditions
Interventions
Treatment Group:Natural Killer cells injection
Control Group:sodium chloride injection
Sponsors
The People’s Hospital of DaZu District,Chongqing
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: All included cases (over 18 years old) must be confirmed as advanced CRC by pathology or cytology.Additionally, they met the following criteria: Eastern Cooperative Oncology Group performance status (ECOG PS) .There will be no restriction on gender, race, or nation. In the same original study, the chemotherapy regimen in the control group of CRC patients is the same as that in the experimental group of CRC patients. The dosage and course of treatment are not limited.
Exclusion criteria
Exclusion criteria: The subjects have interstitial lung disease, autoimmune disease, clinically significant cardiovascular disease, active infection, systemic steroid administration, pregnant women, multiple primary cancers within the previous 5 years, positive human immunodeficiency virus test result , and any other conditions that made the patient unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival, progression-free survival;SafetyEvaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Natural Killer cells markers;Cytokines; | — |
Countries
CHINA
Contacts
Public ContactYu Shaohong
The People’s Hospital of DaZu District,Chongqing
Outcome results
None listed